| 摘要 |
A pharmaceutical composition including a rhizopus ksd-815 strain is provided to realize an effect of preventing and treating diseases related to angiogenesis such as rheumatoid arthritis, diabetic retinitis, solid tumor, hemandioma, psoriasis and cancer. A pharmaceutical composition including a rhizopus ksd-815 strain comprises one or more active ingredients selected from the group consisting of a rhizopus KSD-815 strain, culture material of the strain, fermentation material of the strain, and their extracts. The extracts are obtained from the culture material or fermentation material by water or a C1-C6 organic solvent. The organic solvent is selected from the consisting of methanol, ethanol, propanol, isopropanol, butanol, isoamyl alcohol, hexane and ethylacetate. |
